{
 "url": "http://xueshu.baidu.com/homepage/u/46ec6e5423663d21fbca8611d6a933b3",
 "主题": [
  "周光文"
 ],
 "id": "CN-BF7429SJ",
 "工作单位": "上海第二医科大学附属瑞金医院",
 "被引次数": [
  "2613"
 ],
 "成果数": [
  "310"
 ],
 "H指数": [
  "24"
 ],
 "G指数": [
  "41"
 ],
 "领域": [
  "外科学"
 ],
 "合作者": [
  "李宏为",
  "彭承宏",
  "沈柏用",
  "陈皓"
 ],
 "合作单位": [
  "上海第二医科大学附属瑞金医院",
  "上海交通大学医学院附属瑞金医院",
  "上海交通大学医学院附属瑞金医院",
  "上海交通大学医学院附属瑞金医院"
 ],
 "合作机构": [
  "上海交通大学医学院附属瑞金医院",
  "上海第二医科大学附属瑞金医院",
  "浙江省人民医院",
  "南昌大学第一附属医院",
  "上海交通大学附属第六人民医院",
  "哈尔滨医科大学第一临床医学院普外二科",
  "郑州轻工业学院材料与化学工程学院",
  "复旦大学附属闵行医院",
  "同济大学附属同济医院",
  "浙江省丽水市人民医院"
 ],
 "论文": [
  "贲门周围血管离断术后异位曲张静脉破裂出血的诊治经验(附12例报告)",
  "重视胰源性门静脉高压症的诊治",
  "T细胞免疫球蛋白和黏蛋白3基因rs4704853G/A多态性及与胰腺癌易感相关性",
  "MicroRNA‐191 acts as a tumor promoter by modulating the TET1&ndash;p53 pathway in intrahepatic cholangiocarcinoma",
  "全胰腺及十二指肠切除治疗胰腺导管内乳头状瘤癌变一例",
  "Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial.",
  "235例复杂性脾切除术的临床疗效",
  "胃癌合并门静脉高压症的术式选择及疗效观察",
  "提高门静脉高压症外科手术疗效的策略",
  "肝细胞癌切除术后抗HBV治疗疗效分析",
  "Optimal combination of gemcitabine, sorafenib, and S-1 shows increased efficacy in treating cholangiocarcinoma in vitro and in vivo",
  "Heme Oxygenase-1 Promoter Polymorphism Protects Liver Allograft.",
  "Nucleation and growth of oxide islands during the initial-stage oxidation of (100)Cu-Pt alloys",
  "小鼠骨髓间充质干细胞联合胰岛移植调节Tfh细胞及诱导免疫耐受的机制",
  "丙型肝炎病毒感染与胆管细胞癌发生风险关系的Meta分析",
  "门静脉高压症出血外科治疗维持长期不出血经验",
  "Clinical efficacy of complex splenectomy in 235 patients",
  "Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies."
 ]
}